Evidence map›Paper›PMID 42121658›Full record

ReviewHealthcare (Basel, Switzerland)2026

Modifiable Lifestyle and Environmental Determinants of Ovarian Cancer Risk: Implications for Primary Prevention.

Martina Arcieri, Stefano Restaino, Nicoletta Crivellaro, Giorgio Bogani, Sara Pregnolato, Doriana Armenise, Federico Paparcura, Filippo Bordin, Sara Filippin, Lino Del Pup and 10 more

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Martina ArcieriClinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.ORCID 0000-0002-8257-0618
Stefano RestainoClinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.ORCID 0000-0002-7848-0329
Nicoletta CrivellaroDepartment of Medicine (DMED), University of Udine, 33100 Udine, Italy.ORCID 0009-0000-7571-3599
Giorgio BoganiGynaecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
Sara PregnolatoDepartment of Medicine (DMED), University of Udine, 33100 Udine, Italy.ORCID 0000-0003-1540-1897
Doriana ArmeniseDepartment of Medicine (DMED), University of Udine, 33100 Udine, Italy.ORCID 0009-0007-9531-8159
Federico PaparcuraClinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.ORCID 0009-0007-0881-7233
Filippo BordinDepartment of Medicine (DMED), University of Udine, 33100 Udine, Italy.
Sara FilippinDepartment of Medicine (DMED), University of Udine, 33100 Udine, Italy.ORCID 0009-0001-0933-0503
Lino Del PupAzienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy.
Lorenza DriulClinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.
Fedro Alessandro PeccatoriFertility and Procreation Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0001-8227-8740
Carlo RonsiniUnit of Gynecologic Oncology, National Cancer Institute, IRCCS, Fondazione "G. Pascale", 80131 Naples, Italy.ORCID 0000-0002-9023-282X
Stefano CianciObstetrics and Gynecology Unit, Department of Human Pathology of Adult and Childhood "G. Barresi", University of Messina, 98124 Messina, Italy.ORCID 0000-0002-0548-9891
Guglielmo StabileDepartment of Medical and Surgical Sciences, Institute of Obstetrics and Gynecology, University of Foggia, 71121 Foggia, Italy.ORCID 0000-0001-9266-3896
Federica PerelliPediatric Gynecology Unit, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.ORCID 0000-0002-5508-0875
Vito Andrea CapozziDepartment of Obstetrics and Gynecology, University of Parma, 43125 Parma, Italy.ORCID 0000-0003-4720-5663
Roberto BerrettaDepartment of Obstetrics and Gynecology, University of Parma, 43125 Parma, Italy.ORCID 0000-0003-2324-5409
Giuseppe VizzielliClinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.ORCID 0000-0002-2424-2691
The Italian Women's Ovarian Health And Prevention Collaborative Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer (OC) remains the most lethal gynecologic malignancy worldwide, largely due to late-stage diagnosis and the absence of effective screening strategies. As a result, primary prevention is a critical approach to reducing disease burden. This narrative review summarizes current evidence on modifiable lifestyle, reproductive, and environmental factors associated with OC risk, based on a comprehensive PubMed, MEDLINE, Scopus, and Web of Science search conducted through April 2026. Consistent protective associations have been reported for reproductive factors, including parity, breastfeeding, oral contraceptive use, salpingectomy, and tubal ligation. Among lifestyle factors, excess body weight is modestly associated with increased OC risk, while evidence regarding physical activity remains inconclusive. Diets rich in fiber and aligned with a Mediterranean pattern appear protective, potentially through hormonal modulation and anti-inflammatory effects. In contrast, pro-inflammatory diets high in trans fats and refined carbohydrates may increase risk, whereas omega-3 fatty acids show potential protective benefits. Chronic pelvic inflammation, particularly related to Chlamydia trachomatis infection, has been linked to elevated epithelial OC risk. Smoking demonstrates a dose-response association with mucinous tumors. Environmental exposures, including genital talc use and endocrine-disrupting chemicals such as phthalates and bisphenols, have linked to a possible, albeit modest, increase in risk, although the causal mechanisms remain uncertain. Although individual associations are generally modest, their cumulative population impact may be substantial. Integrating lifestyle-based prevention strategies into gynecologic practice and public health initiatives could represent a cost-effective approach to reducing OC incidence and improving women's health outcomes.

Indexed as

lifestyleovarian cancerprimary prevention

Identifiers

PMID42121658
PMCPMC13163307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.